Houston-based PolyVascular — a MedTech Innovator accelerator participant in 2020 — develops a first-of-its-kind heart valve. The potentially transformative, non-surgical valve could treat young children suffering from congenital heart disease.
New York-based CobiCure, a non-profit pediatric initiative, aims to provide strategic support and resources in addition to the funding. The initiative seeks to further advance the development of the novel polymer heart valve toward human clinical readiness.
According to a news release, the companies hope to accelerate potentially life-saving technology for children born with congenital heart defects.
“CobiCure’s mission, strategic ecosystem, and critica…